Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/74648
Full metadata record
DC FieldValueLanguage
dc.contributor.authorForbes, B.-
dc.contributor.otherA.P.T. Patent and Trade Mark Attorneys-
dc.date.issued2010-
dc.identifier.urihttp://hdl.handle.net/2440/74648-
dc.descriptionPATENT: B. Forbes (Assignee: University of Adelaide). WO 2004/007543 A1 (PCT/AU2003/000898) filed Jul 11, 2003; published Jan 22, 2004-
dc.description.abstractAltered IGFBPs are able to bind IGF but the release is inhibited by resistance to protease cleavage and/or reduced binding to extracellular matrix (ECM). Alterations have been made in IGFBP-2 to the linker domain in particular and two amino acid motifs found to be important for ECM binding. IGF-1 mediated proliferation of cancer cells have been inhibited by the use of these altered IGFBPs.-
dc.description.statementofresponsibilityInvented by B. Forbes; assigened to University of Adelaide; A.P.T. Patent and Trade Mark Attorneys agent for inventors.-
dc.description.urihttp://www.patentlens.net/patentlens/patent/WO_2004_007543_A1/en/-
dc.language.isoen-
dc.subjectWO 2004/007543 A1-
dc.titleAltered Insulin-Like Growth Factor binding Proteins-
dc.typePatent-
dc.contributor.assigneeUniversity of Adelaide-
dc.identifier.patent4559222-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 4
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.